Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1016/j.ccr.2004.08.031
Read article for free, from open access legal sources, via Unpaywall: http://www.cell.com/article/S1535610804002703/pdf
References
Articles referenced by this article (41)
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer.
J Immunol, (1):678-689 2001
MED: 11123353
Isolation of putative progenitor endothelial cells for angiogenesis.
Science, (5302):964-967 1997
MED: 9020076
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.
Nat Cell Biol, (10):737-744 2000
MED: 11025665
Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
Cancer Res, (18):5117-5124 2000
MED: 11016638
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.
Blood, (12):3838-3846 2000
MED: 11090068
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
Nat Med, (5):575-583 2001
MED: 11329059
Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment.
Cancer Res, (5):1675-1686 2004
MED: 14996727
MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.
Cell, (3):481-490 2000
MED: 11081634
Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells.
Nat Med, (6):789-795 2003
MED: 12740570
Show 10 more references (10 of 41)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/101750009
Article citations
CD24 affects the immunosuppressive effect of tumor-infiltrating cells and tumor resistance in a variety of cancers.
Discov Oncol, 15(1):399, 02 Sep 2024
Cited by: 0 articles | PMID: 39222166 | PMCID: PMC11369128
Tissue- and Temporal-Dependent Dynamics of Myeloablation in Response to Gemcitabine Chemotherapy.
Cells, 13(16):1317, 07 Aug 2024
Cited by: 0 articles | PMID: 39195207 | PMCID: PMC11352862
Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis.
Cancers (Basel), 16(14):2556, 16 Jul 2024
Cited by: 0 articles | PMID: 39061196 | PMCID: PMC11275082
Neutrophils in Cancer immunotherapy: friends or foes?
Mol Cancer, 23(1):107, 18 May 2024
Cited by: 8 articles | PMID: 38760815 | PMCID: PMC11102125
Review Free full text in Europe PMC
Enhanced ApcMin/+ adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells.
Neoplasia, 53:101005, 17 May 2024
Cited by: 1 article | PMID: 38761506 | PMCID: PMC11127156
Go to all (743) article citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
Eur J Immunol, 40(1):22-35, 01 Jan 2010
Cited by: 378 articles | PMID: 19941314
Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro.
Biochem Biophys Res Commun, 443(4):1218-1225, 02 Jan 2014
Cited by: 10 articles | PMID: 24388986
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.
Cancer Res, 66(13):6807-6815, 01 Jul 2006
Cited by: 205 articles | PMID: 16818658
Myeloid-derived suppressor cell heterogeneity and subset definition.
Curr Opin Immunol, 22(2):238-244, 17 Feb 2010
Cited by: 439 articles | PMID: 20171075
Review
Funding
Funders who supported this work.
NCI NIH HHS (6)
Grant ID: CA87756
Grant ID: CA076321
Grant ID: CA095103
Grant ID: CA89674
Grant ID: T32 CA009592
Grant ID: 5P50CA90949